Does the pharmacological class effect between the different luteinizing hormone releasing hormone analogues used in the treatment of prostate cancer have to be assumed?

✍ Scribed by S. Vilar-González; X. Maldonado-Pijuan; I. Andrés-García

• Book ID: 119648864
• Publisher: Elsevier
• Year: 2010
• Weight: 230 KB
• Volume: 34
• Category: Article
• ISSN: 2173-5786
• DOI: 10.1016/s2173-5786(10)70190-6